Business
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.
WOODSTOCK, Ga.--(BUSINESS WIRE)-- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn®
About this update from Sonoma Pharmaceuticals, Inc.
[{"type":"text","content":" WOODSTOCK, Ga.--(BUSINESS WIRE)--\nSonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions and disinfectant use, and its partner, the MicroSafe Group DMCC, received EPA approval for Nanocyn® as a hospital-grade disinfectant in the United States. Nanocyn®, which is manufactured by Sonoma using its patented Microcyn® Technology, is a ready to use hard-surface disinfectant that may reduce the risk of infection by treating hard, non-porous surfaces, making it especially useful in high-risk areas such as hospitals, schools, mass transit, and care facilities.\n\nNanocyn® hospital-grade disinfectant is currently sold by MicroSafe Group in Europe, the Middle East/West Africa and Australia. Nanocyn has been proven to kill a variety of bacteria, such as Staphylococcus aureus and Pseudomonas aeruginosa, and has a 30 second kill time for many viruses, including norovirus, on hard non-porous surfaces. In May 2020, Nanocyn was entered into the Australian Register of Therapeutic Goods (ARTG) for use against SARS-CoV-2 (COVID-19). Nanocyn utilizes Sonoma’s patented Microcyn technology which has a long, proven record of significantly reducing numerous bacteria, viruses, fungi and spores on many surfaces. For more information see www.sonomapharma.com/literature/.\n\nThe EPA approval process was a coordinated effort by Sonoma and MicroSafe Group. MicroSafe Group managed and financed the regulatory process with the EPA in exchange for non-exclusive rights to distribute Nanocyn in the United States. Sonoma provided expertise and manufactured the required product samples.\n\n“The MicroSafe Group is very pleased with the EPA approval of Nanocyn® hospital-grade disinfectant, known as MicroSafe® disinfectant in Europe, the Middle East/West Africa and Australia. The EPA approval validates over 20 years of research, development and independent testing that determines the unique stability and efficacy of Microcyn® Technology, a revolution in stable HOCl,” said Safwan Abdallah, COO of the MicroSafe Group. “Furthermore, Nanocyn®’s extraordinarily low toxicity profile as categorized by the EPA (lowest Category IV per 40 CFR 156.62) means...